Company Filing History:
Years Active: 2023
Title: Innovations in Ocular Drug Delivery by Peter McLoughlin
Introduction
Peter McLoughlin is an innovative inventor based in Waterford, Ireland. He has made significant contributions to the field of ocular drug delivery through his patented invention. His work focuses on enhancing the effectiveness of therapeutic agents for eye disorders.
Latest Patents
Peter McLoughlin holds a patent for a novel Ocular Drug Delivery system. This invention relates to a Nanostructured Lipid Carrier (NLC) particle that encapsulates a therapeutic agent for ocular delivery. The NLC particle consists of a solid outer shell made of solid lipid and a liquid core containing a liquid lipid. The core is designed to include the therapeutic agent, which enhances its delivery to the eye. The patent also covers compositions of the NLC particles, their use, methods for treating or preventing eye disorders, and an eye drop dispenser.
Career Highlights
Peter McLoughlin is affiliated with the Waterford Institute of Technology, where he continues to advance research in ocular drug delivery. His work has the potential to improve treatment options for patients suffering from various eye conditions.
Collaborations
Peter has collaborated with notable colleagues, including Gautam Behl and Sangeeta Kumari, to further his research and development efforts in this innovative field.
Conclusion
Peter McLoughlin's contributions to ocular drug delivery through his patented invention demonstrate his commitment to advancing medical technology. His work has the potential to significantly impact the treatment of eye disorders and improve patient outcomes.